Yuanyuan Zhao, Yan Huang, Hong Liu, Bijing Xiao, Li Zhang. "Multi-omic analysis and overall survival update of phase II TRIDENT study: Durvalumab plus olaparib in extensive-stage small-cell lung cancer (ES-SCLC).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.8101